https://www.marketscreener.com/quote/stock/ALEXION-PHARMACEUTICALS-I-8334/news/Alexion-Pharmaceuticals-FDA-Accepts-sBLA-Filing-of-Soliris-Eculizumab-as-a-Potential-Treatment-24004368/?utm_source=telegram&utm_medium=social&utm_campaign=share